{"retracted":false,"update":{"timestamp":1409961600000,"doi":"10.1007/s12672-014-0201-2","type":"correction"},"doi":"10.1007/s12672-014-0182-1","journal":"Hormones and Cancer","publisher":"Springer Nature","title":"Erratum to: The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial"}
